Autologous T cell gene therapy: Phase II trial

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: Autologous T cell gene therapy Indication: HIV Status: CEGE will start this quarter an open label Phase II trial in which patients' T cells will ...